Contents

Search

fruquintinib

Indications: - metastatic colorectal adenocarcinoma

General

small inhibitory antineoplastic agent (ib drug) heterocyclic compound, 2 rings

Database Correlations

PUBCHEM cid=44480399

References

  1. Li J, Qin D, Xu RH et al Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer. The FRESCO Randomized Clinical Trial. JAMA. 2018;319(24):2486-2496 https://jamanetwork.com/journals/jama/fullarticle/2685988